A decades-old drug, long used to treat conditions including a chronic parasitic disease, may soon offer new hope.. Share this
News & Media
We are pleased to announce a new partnership with Every Cure. Every Cure is a U.S.-based nonprofit on a mission to save and improve lives
Dr. Fajgenbaum is being honored for his groundbreaking work advancing drug repurposing Share this
Share this
When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started to feel so tired that he could barely stand. Share
Every Cure, a nonprofit working to reveal the untapped potential of existing medications, has emerged as the overall winner of Newsweek’s inaugural AI Impact Awards. Share this
We’re proud to share that Every Cure Co-Founder and President, Dr. David Fajgenbaum, has been named to the 2025 TIME100 Health list, a prestigious recognition
A little over a year ago, Joseph Coates was told there was only one thing left to decide. Share this
Click the video above to watch a story that ran on CBS Evening News about leucovorin for ASD. Share this
Every year, millions of patients suffer from diseases that lack effective treatments… Share this
Set to enter hospice care, a patient with idiopathic multicentric Castleman’s disease is now in remission after treatment with a medication predicated as the top
Every Cure is excited to highlight the potential role that folinic acid (leucovorin) may play in improving verbal communication in some individuals with speech challenges
Every Cure will leverage Google Cloud’s infrastructure and AI technologies, including Gemini 2.0, to accelerate discoveries and improve patient outcomes Share this
This support will enable Every Cure to evaluate the most promising treatments identified by its ARPA-H-funded AI platform in laboratory and clinical studies, with the
An organization scouring thousands of existing drugs to see if any can cure hard-to-treat diseases has a powerful new ally: former FDA official Janet Woodcock.
Grant Mitchell discusses Every Cure’s mission, challenges in health tech entrepreneurship, impact assessment, future innovations, and advice for aspiring entrepreneurs. Share this
Rare diseases often require innovative treatments, but not always brand-new ones. This research nonprofit deploys AI as a matchmaker between doctors and existing medications. Share
We are excited to bring you our newest patient documentary about Kaila, a rare disease patient whose life was saved thanks to a repurposed drug
The alliance will focus specifically on enhancing clinical trials and their outcomes to boost trial success rates and the efficient use of capital by drug
